Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: Further support about the concept of tumor dormancy

Breast Cancer Research and Treatment

Volumn 41, Issue 2, 1996, Pages 177-185

  Demicheli, Romano ^a   Abbattista, Antonello ^a   Miceli, Rosalba ^a   Valagussa, Pinuccia ^a   Bonadonna, Gianni ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Breast cancer; Metastasis growth; Recurrence risk; Tumor dormancy

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RECURRENCE; CANCER RISK; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MENOPAUSE; METASTASIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TREATMENT FAILURE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 0029851451     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01807163     Document Type: Article

References (35)

1. Simes RJ, Zelen M: Exploratory data analysis and the use of the hazard function for interpreting survival data: an investigator's primer. J Clin Oncol 3: 1418-1431, 1985
2. Norton L: Implications of kinetic heterogeneity in clinical oncology. Sem Oncol 12: 231-249, 1985
3. Demicheli R, Valagussa P, Foroni R, Bonadonna G: Mean relapse rate per year (MRR/Y) suggests different biological conditions of breast cancer micrometastases at the time of primary local-regional treatment. Proc Am Soc Clin Oncol 12: 119, 1993
4. Fidler I: The biology of renal cancer metastasis. Semin Urol 1: 3-11, 1992
5. Marubini E, Valsecchi MG: Analysing survival data from clinical trials and observational studies. Wiley & Sons Ltd, Chichester (UK) 1995, pp 331-364
6. Prentice RL, Kalbfleisch JD, Peterson AV Jr: The analysis of failure times in the presence of competing risks. Biometrics 34: 541-554, 1978
7. Ramlau-Hansen H: Smoothing counting process intensities by means of Kernel functions. Ann Statistics 11: 453-466, 1983
8. Efron B: Logistic regression, survival analysis, and Kaplan-Meier curve. J Am Stat Ass 83: 414-425, 1988
9. Veronesi U, Marubini E, DelVecchio M, Manzari A, Andreola S, Greco M, Luini A, Merson M, Saccozzi R, Rilke F, Salvadori B: Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 87: 19-27, 1995
10. Kennedy MJ, Abeloff MD: Management of locally recurrent breast cancer. Cancer 71: 2395-2409, 1992
11. Valagussa P, Bonadonna G, Veronesi U: Patterns of relapse and survival following radical mastectomy. Cancer 41: 1170-1178, 1978
12. Kamby C: The pattern of metastases in human breast cancer: methodological aspects and influence of prognostic factors. Cancer Treat Rev 17: 37-61, 1990
13. Gilchrist KW, Gray R, Fouble B, Tormey DC, Taylor IV SG: Tumor necrosis is a prognostic predictor for early recurrence and death in lymphnode-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients. J Clin Oncol 11: 1929-1935, 1993
14. Yoshimoto M, Sakamoto G, Ohashi Y: Time dependency of the influence of prognostic factors on relapse in breast cancer. Cancer 72: 2993-3001, 1993
15. Fisher B, Bauer M, Wickerhan DL, Redmond CK, Fisher ER: Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 52: 1551-1557, 1983
16. Gehan EA: Estimating survival functions from the life table. A J Chron Dis 21: 629-644, 1969
17. Fisher E, Fisher B, Sass R, Wickerham L and Collaborating NSABP Investigators: Pathologic findings from the National Surgical Adjuvant Breast Project (protocol # 4). XI. Bilateral breast cancer. Cancer 54: 3002-3011, 1984
18. Dawson PJ, Maloney T, Gimotty P, Juneau P, Ownby H, Wolman SR: Bilateral breast cancer: one disease or two? Breast Cancer Res Treat 19: 233-244, 1991
19. Chaudary MA, Millis RR, Hoskins EO, Halder M, Bulbrook RD, Cuzick J, Hayward JL: Bilateral primary breast cancer: a prospective study of disease incidence. Br J Surg 71: 711-714, 1984
20. Healey EA, Cook EF, Orav EJ, Schnitt SJ, Connolly JL, Harris JR: Contralateral breast cancer: clinical characteristics and impact on prognosis. J Clin Oncol 11: 1545-1552, 1993
21. Rosen PP, Groshen S, Kinne DW, Norton L: Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up. J Clin Oncol 11: 2090-2100, 1993
22. Spratt JS, Spratt TL: Rates of growth of pulmonary metastases and host survival. Ann Surg 159: 161-171, 1964
23. Uhr JW, Tucker T, May RD, Siu H, Vitetta ES: Cancer dormancy: studies of the murine BCL1 lymphoma. Cancer Res 51: 5045s-5053s, 1991
24. Wijsman JH, Cornelisse CJ, Keijzer R, van de Velde CJH, van Dierendonck JH: A prolactin dependent, metastasising rat mammary carcinoma as a model for endocrine-related tumor dormancy. Br J Cancer 64: 463-468, 1991
25. Gartner MF, Fearns C, Wilson EL, Campbell JAH, Dowdle EB: Unusual growth characteristics of human melanoma xenografts in the nude mouse: a model for desmoplasia, dormancy and progression. Br J Cancer 65: 487-490, 1992
26. Shafie SM, Grantham FH: Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. J Natl Cancer Inst 67: 51-56, 1981
27. Holmgren L, O'Reilly MS, Folkman J: Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med 1: 149-153, 1995
28. Pantel K, Schlimok G, Braun S: Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 85: 1419-1424, 1993
29. Demicheli R, Terenziani M, Valagussa P, Moliterni A, Zambetti M, Bonadonna G: Local recurrences following mastectomy: support for the concept of tumor dormancy. J Natl Cancer Inst 86: 45-18, 1994
30. Killion JJ, Fidler U: The biology of tumor metastasis. Semin Oncol 16: 106-115, 1989
31. Sobel ME: Metastasis suppressor genes. J Natl Cancer Inst 82: 267-276, 1990
32. Nicolson GL: Molecular mechanisms of cancer metastasis: tumor and host properties and the role of oncogenes and suppressor genes. Curr Opin Oncol 3: 75-92, 1991
33. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6, 1990
34. Fisher B, Gunduz N, Coile J, Rudock C, Saffer E: Presence of a growth-stimulating factor in serum following primary tumor removal in mice. Cancer Res 49: 1996-2001, 1989
35. Valagussa P, Brambilla C, Zambetti M, Bonadonna G: Salvage treatments in relapsing resectable breast cancer. Recent Results in Cancer Research 115: 69-76, 1989